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A total of 98 vancomycin-resistant Enterococcus faecium (VREF) isolates from four tertiary-care hospitals in
Korea during the period between 1998 and 2004 were analyzed for genotypic characteristics using the multiplex
PCR, multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), and esp gene analysis.
Ninety-two isolates of VREF with VanA phenotype and five of six isolates with VanB phenotype possessed the
vanA gene. MLST analysis revealed 9 sequence types (STs), which belonged to a single clonal complex (CC78,
clonal lineage C1). Five strains showing incongruence between phenotype and genotype (VanB-vanA) did not
belong to the same genotypic clone. The esp gene was detected in all VREF strains, showing 12 different esp
repeat profiles. Data suggest that an epidemic clonal group of VREF, CC78 with esp gene, is also present in Asia
and has differentiated into multiple diverse genotypic clones during the evolutionary process.
Since the first isolation of vancomycin-resistant Enterococcus
faecalis and Enterococcus faecium in 1988 (17), vancomycin-
resistant enterococci (VRE) have become one of the major
threats to public health in many parts of the world. Although
E. faecalis is more common in human infections, vancomycin
resistance is more frequently observed in E. faecium isolates.
Most vancomycin-resistant E. faecium (VREF) strains isolated
in Korea showed the VanA phenotype, which is defined as
having high-level resistance to vancomycin and teicoplanin (2).
VREF isolates with the VanB phenotype characterized by vari-
able levels of resistance to vancomycin but by susceptibility to
teicoplanin have been reported in Korea since 1997 (12). Gen-
erally, the vanA gene cluster confers the VanA phenotype and
vanB gene cluster is associated with the VanB phenotype.
Recently, however, VRE strains with the vanA gene and VanB
phenotype have been found in Japan, Taiwan, and Korea (3, 6,
8, 11).
VREF is an important concern not only because VREF
infection is difficult to treat in clinical practice but also because
VREF clones can spread within hospitals as well as between
regions or countries. Molecular epidemiologic studies could
clarify the genetic relatedness and molecular evolution of
VREF clones. In the current study, we have investigated the
phenotypic and genotypic characteristics of VREF isolates
from four tertiary-care hospitals in Korea by using the broth
microdilution test, pulsed-field gel electrophoresis (PFGE),
multilocus sequence typing (MLST), and analysis of the esp
repeat profile.
MATERIALS AND METHODS
VREF isolates. A total of 98 vancomycin-resistant E. faecium (VREF) isolates
from four tertiary-care hospitals in Korea (Samsung Medical Center, Severans
Hospital, Kyunghee University Hospital, and Kyungbuk National University
Hospital) were analyzed in this study. The most common specimen source was
urine (25 isolates) followed by rectal swab (14 isolates), blood (13 isolates), pus
(9 isolates), wound (5 isolates), fluid (5 isolates), sputum (2 isolates), and tissue
(2 isolates). Duplicate strains from the same patient were not included in the
study. Antimicrobial resistance to vancomycin and teicoplanin were determined
by measuring the MIC using broth dilution method according to the National
Committee for Clinical Laboratory Standards (NCCLS) procedures (14).
Genomic DNA for molecular analysis was extracted by a simple boiling-lysis
method. The DNA from each of the VREF strains was analyzed by multiplex
PCR method for the presence of vancomycin resistance gene (1).
MLST analysis. MLST was performed as described previously (7, 19), based
on seven housekeeping genes (atpA, ddl, gdh, purK, gyd, pstS, and adk). The allele
number for each gene was assigned based on the E. faecium MLST database
(http://efecium.mlst.net). Allelic profiles were represented as a series of 7 inte-
gers corresponding to the alleles at each of the loci, in the order of atpA, ddl, gdh,
purK, gyd, pstS, and adk. Sequence type (ST) was designated for each unique
allelic profile.
esp gene analysis. The presence of the esp gene was determined by use of a
primer set (forward, 5-GGT CAC AAA GCC CAA CTT GT-3; reverse,
5-ACG TCG AAA GTT CGA TTT CC-3), which is expected to amplify 407-bp
fragments (20). To determine repeat number variations of esp A and C repeats,
two different primer combinations were used; espfs7F-espfm5R and espfm5F-
espfs3R, respectively (9). The PCR products were subjected to agarose gel elec-
trophoresis (1%) and the numbers of repeats were deduced from the sizes of the
amplified fragments (9).
Pulsed-field gel electrophoresis. PFGE was performed as previously described
(13). Agarose plugs containing genomic DNA were digested with SmaI (Gibco,
BRL, Gaithersburg, Md.) according to the manufacturer’s recommendations.
Electrophoresis was performed with a CHEF-Mapper apparatus (Bio-Rad Lab-
oratories, Milan, Italy), at 6 V/cm for 22 h. The PFGE patterns were interpreted
using the criteria suggested by Tenover et al. (16).
RESULTS
Ninety-two of 98 VREF isolates (93.9%) showed the VanA
phenotype with resistance to both vancomycin and teicoplanin,
while six strains were resistant to vancomycin but susceptible to
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teicoplanin (VanB phenotype). Of these six VREF isolates
with the VanB phenotype, only one possessed the vanB gene,
whereas five isolates showed incongruence between phenotype
and genotype (VanB phenotype and vanA genotype).
Ninety-eight VREF isolates showed nine sequence types
(STs) in MLST analysis, including five newly identified STs
(STs 203, 204, 205, 206, and 207) (Table 1). The predominant
ST was ST78 (58 strains, 59.2%), followed by ST192 (13.3%),
ST203 (12.2%), and ST17 (7.1%). The other STs included one
or two VREF isolates. STs 192, 203, 17, 204, 117, and 205 are
single-locus variants of ST78. ST207 is a single-locus variant of
ST203, and ST206 is a double-locus variant of ST17. Thus, the
MLST data suggested that all VREF isolates in this study
belong to one clonal complex, CC78 (Fig. 1).
In CC78, eight types of allelic variations have been identified
due to either point mutation or recombinational process (4, 5).
Three variations in the allelic profile of the atpA locus were
due to the recombination (Fig. 1). All strains had the type 1
allele of the purK gene, which have been reported to be related
to epidemic VREF strains (10, 18).
The esp gene was detected in all VREF isolates analyzed in
this study. Among 98 VREF strains, the numbers of the A and
C repeats of the esp gene varied from 3 to 7 and from 3 to 8,
respectively (Table 1). Based on the esp A and C repeat profile,
VREF isolates belonged to 12 different groups. The most prev-
alent esp profile was A6-C5 (59 isolates [60.2%]), followed by
A5-C6 (14 isolates [14.3%]), A6-C3 (6 isolates [6.1%]), A4-C5
(5 isolates [5.1%]), and A5-C7 (4 isolates [4.1%]). The other
esp profiles were displayed by only one or two strains. Isolates
with the same STs showed different esp repeat profiles. There-
fore, based on MLST and esp repeat profiles, a total of 29
genotypic clones were identified. Fifty-eight VREF isolates
with ST78 showed eight esp repeat profiles, while ST192 and
ST203 showed four and five different esp repeat profiles, re-
spectively (Table 1). Overall, the most common genotypic
clone among Korean VREF isolates was ST78 with A6-C5 esp
repeat profile (ST78-A6-C5) (41 isolates [41.8%]). Including
that clone, there were nine genotypic clones that contained
multiple VREF isolates; the eight others were ST192-A6-C5
(10 isolates), ST78-A5-C6 (8 isolates), ST203-A5-C6 (4 iso-
lates), ST203-A6-C5 (4 isolates), ST78-A4-C5 (2 isolates),
ST203-A5-C7 (2 isolates), ST17-A5-C8 (2 isolates), and ST17-
A4-C5 (2 isolates). Five VREF strains showing incongruence
between phenotype and genotype of vancomycin resistance
belonged to ST78 (4 isolates) and ST203 (1 isolate). The esp
repeat profiles of these strains showed four different types, as
follows: A4-C3 (2 isolates), A6-C5 (1 isolate), A4-C5 (1 iso-
late), and A7-C6 (1 isolate). Based on MLST and esp gene
analysis, these five strains showed genetic backgrounds that
were different from each other (Table 2 ). PFGE patterns also
showed that these five strains do not belong to the same clone
(Fig. 2).
DISCUSSION
In the current study, we investigated the genetic character-
istics of VREF isolates from Korea by MLST, PFGE, and esp
repeat profiles. Each method had a different ability to analyze
the genotypes of VREF isolates. MLST based on seven house-
keeping genes such as atpA, ddl, gdh, purK, gyd, pstS, and adk
has identified nine different STs of VREF isolates in this study,
while PFGE has shown more than 32 distinguishable fragment
patterns (data not shown). Isolates with different PFGE pat-
tern belonged to the same ST on MLST. Therefore, MLST is
usually useful for long-term and evolutionary process of resis-
TABLE 1. Genotypic characteristics of vancomycin-resistant E.
faecium isolates from four Korean hospitals based on multilocus
sequence typing and esp repeat profiles
ST (allelic profile) No. ofstrains (%)
esp gene repeat
profile No. of
strains (%)
esp-A esp-C
78 (15-1-1-1-1-1-1) 58 (59.2) 7 6 1 (1.0)
6 5 41 (41.8)
6 4 1 (1.0)
6 3 1 (1.0)
5 6 8 (8.2)
5 3 1 (1.0)
4 5 2 (2.0)
4 3 1 (1.0)
192 (15-1-1-1-1-7-1) 13 (13.3) 6 5 10 (12.8)
5 7 1 (1.0)
5 6 1 (1.0)
4 5 1 (1.0)
203 (15-1-1-1-1-20-1) 12 (12.2) 6 5 4 (4.1)
6 3 1 (1.0)
5 7 2 (2.0)
5 6 4 (4.1)
4 3 1 (1.0)
17 (1-1-1-1-1-1-1) 7 (7.1) 6 6 1 (1.0)
6 3 1 (1.0)
5 8 2 (2.0)
5 7 1 (1.0)
4 5 2 (2.0)
204 (15-1-6-1-1-1-1) 2 (2.0) 7 6 1 (1.0)
6 3 1 (1.0)
206 (1-3-1-1-1-1-7) 2 (2.0) 6 5 1 (1.0)
3 4 1 (1.0)
117 (9-1-1-1-1-1-1) 1 (1.0) 5 6 1 (1.0)
205 (3-1-1-1-1-1-1) 1 (1.0) 6 3 1 (1.0)
207 (3-1-1-1-1-20-1) 1 (1.0) 6 3 1 (1.0)
TABLE 2. Characteristics of five vancomycin-resistant E. faecium isolates with VanB phenotype-vanA genotype
Isolate
no.
Yr of
isolation Source
MIC (mg/liter)
ST (allelic profile)
esp repeat profile
Vancomycin Teicoplanin esp-A esp-C
98-2 1998 Pus 64 8 ST78 (15-1-1-1-1-1-1) 7 6
99-3 1999 Sputum 64 8 ST78 (15-1-1-1-1-1-1) 4 3
00-1 2000 Other 64 16 ST203 (15-1-1-1-1-20-1) 4 3
02-4 2002 Urine 64 8 ST78 (15-1-1-1-1-1-1) 6 5
03-22 2003 Rectal swab 64 4 ST78 (15-1-1-1-1-1-1) 4 5
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tant clones, and PFGE is more adequate for short-term epi-
demiologic study. We have also used esp repeat profiles to
analyze the VREF isolates. Previous report showed that strains
originating from a single outbreak had identical esp repeat
profiles, which were relatively stable (9). The esp repeat pro-
files could be utilized to investigate the outbreaks of resistant
clones in combination with other genotyping methods (9). In
our study, combination of the esp repeat profiles and MLST
has increased the diversity of genotypes of VREF isolates. For
instance, ST78 from MLST showed eight different esp repeat
profiles. Thus, combination of MLST and esp repeat profiles
could be more discriminatory in evaluating the genotypes of
clinical isolates of VREF.
In this study, MLST and the esp repeat profiles suggested the
epidemic nature of VREF isolates based on STs, purK-1 allele,
and presence of esp gene (7, 10). All VREF isolates in this
study belonged to CC78 with the purK-1 allele. Previous study
showed that CC78 belongs to a subgroup of E. faecium, lineage
C1 (7). The lineage C1 represents a cluster of epidemic E.
faecium strains that has disseminated worldwide (7, 10). The
esp gene that encodes the virulence-associated surface protein
is uniquely present in the strains of this lineage (7, 10, 18).
Therefore, the presence of the esp gene is suggestive of epide-
micity of VREF isolates (9, 19).
In this study, the esp gene was detected in all VREF strains
and the vanA gene complex was found in 97 of 98 isolates,
which suggested the clonal nature of the isolates. Therefore,
our data documented that epidemic clonal group CC78 with
the esp gene is also present in Asia as it is in Europe, the
United States, and Australia (7). However, PFGE and the esp
gene repeat profiles showed multiple genotypes of VREF iso-
lates, which were not consistent with the result of MLST. It is
assumed that one clone of ancestral VREF lineages with esp
gene has been differentiated into multiple diverse genotypic
clones during evolutionary process.
Another interesting finding from this study was incongru-
ence between phenotype and genotype for glycopeptide resis-
tance in five VREF isolates. Of these, one isolate has caused
acute bacterial meningitis, resulting in death of patient, and
other isolates were isolated from wound and urinary tract in-
fections. These five isolates were not related either epidemio-
logically or genetically. Therefore, these VREF isolates with
the VanB phenotype and vanA genotype might have occurred
independently. Previous studies have suggested that point mu-
tations in the sensor domain of vanS gene (3, 6, 8) or impair-
ment of accessory proteins VanY and VanZ (3, 6, 11, 15)
FIG. 1. Speculative evolution of vancomycin-resistant E. faecium isolates analyzed in this study. Alterations in the allelic profile compared with
ST78 are underlined. The number of strains for each ST is indicated in parentheses. The potential reason for allelic variations is shown as R
(recombination) or PM (point mutation) in the corresponding housekeeping gene (parentheses).
FIG. 2. SmaI macrorestriction patterns resolved in PFGE of five
VREF isolates with the VanB phenotype and vanA genotype.
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would be the reason for loss of teicoplanin resistance in these
strains. In the present study, three strains with the VanB phe-
notype and vanA genotype showed an IS1216V insertion into
the vanX-vanY intergenic region accompanied by partial or
whole deletion of vanY or vanZ. However, we could not find
distinct mutations that may be responsible for teicoplanin sus-
ceptibility in another isolates. Further investigation to eluci-
date other molecular mechanism of incongruence is under way.
In summary, we characterized 98 VREF strains isolated
from four tertiary-care hospitals in Korea by molecular typing
methods. Most of the isolates showed the VanA phenotype-
vanA genotype, but five isolates showed VanB phenotype-
vanA genotype. All VREF strains belonged to one clonal com-
plex (CC78) which is related to a globally epidemic E. faecium
clone. Based on MLST and the esp gene repeat profiles, this
clone might have been differentiated into 29 genotypic clones.
The combination of MLST and the esp repeat profiles would
be useful for genetic characterization of VREF isolates with
regard to the evolutionary process and epidemicity of the
clones.
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